Assignee
RHONE POULENC RORER PHARMA
US·108 granted patents·5,288 citations·filing 1988–1999
Top patents by PatentIndex Score
108 records- 0199USRE36256EBis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1997·Granted Jul 20, 1999·183 cites·20 claims
- 0299US5646153ABis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1995·Granted Jul 8, 1997·259 cites·18 claims
- 0399US5480883ABis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1993·Granted Jan 2, 1996·383 cites·20 claims
- 0499US5302606AStyryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1991·Granted Apr 12, 1994·284 cites·12 claims
- 0598US5710158AAryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1994·Granted Jan 20, 1998·339 cites·14 claims
- 0698US5561134ACompounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic propertiesRHONE POULENC RORER PHARMA·Filed 1994·Granted Oct 1, 1996·143 cites·26 claims
- 0798US5364862ACompounds having antihypertensive and anti-ischemic propertiesRHONE POULENC RORER PHARMA·Filed 1992·Granted Nov 15, 1994·141 cites·18 claims
- 0897US5721237AProtein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation propertiesRHONE POULENC RORER PHARMA·Filed 1995·Granted Feb 24, 1998·245 cites·13 claims
- 0997US5714493AAryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1994·Granted Feb 3, 1998·176 cites·1 claims
- 1097US5656643ABis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1995·Granted Aug 12, 1997·258 cites·4 claims
- 1197US5409930ABis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1992·Granted Apr 25, 1995·314 cites·13 claims
- 1296US5691176ARecombinant adeno-associated virus vector packaging cells and methods for useRHONE POULENC RORER PHARMA·Filed 1995·Granted Nov 25, 1997·193 cites·14 claims
- 1396US4996234AHMG-CoA reductase inhibitorsRHONE POULENC RORER PHARMA·Filed 1989·Granted Feb 26, 1991·48 cites·8 claims
- 1495US5795889ABis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1995·Granted Aug 18, 1998·59 cites·17 claims
- 1595US5001128AHMG-COA reductase inhibitorsRHONE POULENC RORER PHARMA·Filed 1989·Granted Mar 19, 1991·51 cites·19 claims
- 1695US4992429ANovel HMG-COA reductase inhibitorsRHONE POULENC RORER PHARMA·Filed 1989·Granted Feb 12, 1991·53 cites·19 claims
- 1794US5589377ARecombinant adeno-associated virus vectorsRHONE POULENC RORER PHARMA·Filed 1995·Granted Dec 31, 1996·121 cites·8 claims
- 1894US5001144ASubstituted cyclohexene derivatives as HMG-CoA reductase inhibitorsRHONE POULENC RORER PHARMA·Filed 1990·Granted Mar 19, 1991·53 cites·10 claims
- 1994US4994494AHMG-COA reductase inhibitorsRHONE POULENC RORER PHARMA·Filed 1989·Granted Feb 19, 1991·48 cites·19 claims
- 2092US5736554ACompounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic propertiesRHONE POULENC RORER PHARMA·Filed 1995·Granted Apr 7, 1998·102 cites·8 claims
- 2192US5596020AAmino bi- and tri-carbocyclic alkane bis-aryl squalene synthase inhibitorsRHONE POULENC RORER PHARMA·Filed 1994·Granted Jan 21, 1997·43 cites·12 claims
- 2290US5612353ASubstituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compoundsRHONE POULENC RORER PHARMA·Filed 1995·Granted Mar 18, 1997·59 cites·12 claims
- 2390US5385912AMulticyclic tertiary amine polyaromatic squalene synthase inhibitorsRHONE POULENC RORER PHARMA·Filed 1992·Granted Jan 31, 1995·80 cites·12 claims
- 2489US5656598AUse of fibroblast growth factors to stimulate bone growthRHONE POULENC RORER PHARMA·Filed 1995·Granted Aug 12, 1997·89 cites·37 claims
- 2589US5468898ASubstituted naphthylene compounds exhibiting selective leukotriene B4 antagonist activityRHONE POULENC RORER PHARMA·Filed 1991·Granted Nov 21, 1995·34 cites·6 claims
- 2688US5605884AFactor VIII formulations in high ionic strength mediaRHONE POULENC RORER PHARMA·Filed 1994·Granted Feb 25, 1997·93 cites·6 claims
- 2788US5571506AAromatic oligomeric compounds useful as mimics of bioactive macromoleculesRHONE POULENC RORER PHARMA·Filed 1993·Granted Nov 5, 1996·47 cites·32 claims
- 2887US5681731AMethod for producing recombinant adeno-associated virus vectorsRHONE POULENC RORER PHARMA·Filed 1995·Granted Oct 28, 1997·51 cites·25 claims
- 2987US5494918AMulticyclic tertiary amine polyaromatic squalene syntase inhibitorsRHONE POULENC RORER PHARMA·Filed 1994·Granted Feb 27, 1996·30 cites·11 claims
- 3087US5441946APhosphonate derivatives of lipophilic aminesRHONE POULENC RORER PHARMA·Filed 1994·Granted Aug 15, 1995·34 cites·17 claims
- 3186US5652366ADI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereofRHONE POULENC RORER PHARMA·Filed 1995·Granted Jul 29, 1997·93 cites·2 claims
- 3285US5730713ARemoval of selected factors from whole blood or its componentsRHONE POULENC RORER PHARMA·Filed 1996·Granted Mar 24, 1998·91 cites·42 claims
- 3384US5132312ASubstituted cyclohexene derivatives as HMG-CoA reductase inhibitorsRHONE POULENC RORER PHARMA·Filed 1990·Granted Jul 21, 1992·42 cites·20 claims
- 3483US5780280ARecombinant adeno-associated virus vectorsRHONE POULENC RORER PHARMA·Filed 1995·Granted Jul 14, 1998·40 cites·12 claims
- 3583US5053392ANovel arginine, glycine, aspartic acid derivatives as platelet-aggregation inhibitorsRHONE POULENC RORER PHARMA·Filed 1989·Granted Oct 1, 1991·45 cites·8 claims
- 3682US5563128APhosphonate derivatives of lipophilic aminesRHONE POULENC RORER PHARMA·Filed 1995·Granted Oct 8, 1996·31 cites·22 claims
- 3782US5162336ATetrahydro-pyrido-indoles as cholecystokinin and gastrin antagonistsRHONE POULENC RORER PHARMA·Filed 1990·Granted Nov 10, 1992·27 cites·20 claims
- 3880US6034093ASubstituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compoundsRHONE POULENC RORER PHARMA·Filed 1998·Granted Mar 7, 2000·28 cites·30 claims
- 3979US5863888AHuman Bek Fibroblast growth factor receptorRHONE POULENC RORER PHARMA·Filed 1995·Granted Jan 26, 1999·37 cites·9 claims
- 4078US5541109AExpression cloning of c-src SH3-domain binding proteinsRHONE POULENC RORER PHARMA·Filed 1994·Granted Jul 30, 1996·54 cites·18 claims
- 4178US5064814AAnti-thrombotic peptide and pseudopeptide derivativesRHONE POULENC RORER PHARMA·Filed 1990·Granted Nov 12, 1991·40 cites·7 claims
- 4277US5413782ABinding pharmaceuticals to ion exchange resinsRHONE POULENC RORER PHARMA·Filed 1992·Granted May 9, 1995·55 cites·13 claims
- 4377US5210208ADisubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activityRHONE POULENC RORER PHARMA·Filed 1990·Granted May 11, 1993·18 cites·20 claims
- 4476US5861314AAdeno-associated viral (AAV) liposomes and methods related theretoRHONE POULENC RORER PHARMA·Filed 1995·Granted Jan 19, 1999·28 cites·5 claims
- 4576US5677329AStyryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1995·Granted Oct 14, 1997·15 cites·16 claims
- 4676US5041453AQuinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4RHONE POULENC RORER PHARMA·Filed 1990·Granted Aug 20, 1991·42 cites·29 claims
- 4774US5731315ASubstituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compoundsRHONE POULENC RORER PHARMA·Filed 1996·Granted Mar 24, 1998·20 cites·44 claims
- 4873US5451596ACycloalkyl amine bis-aryl squalene synthase inhibitorsRHONE POULENC RORER PHARMA·Filed 1992·Granted Sep 19, 1995·15 cites·22 claims
- 4973US5002944ACompounds having cardiotonic activityRHONE POULENC RORER PHARMA·Filed 1989·Granted Mar 26, 1991·10 cites·5 claims
- 5072US5246942APharmaceutically useful dibenzofurancarboxamides of specific stereo-configurationRHONE POULENC RORER PHARMA·Filed 1992·Granted Sep 21, 1993·12 cites·18 claims
Showing the top 50 of 108 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when RHONE POULENC RORER PHARMA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →